Weight Loss
Research Brief
How the Body Defends Its Weight: Comparing T3, Leptin, and NEAT Responses to Calorie Restriction
5 sources · 4d ago
Explainer
The Physiology of Energy Expenditure: Comparing BMR, NEAT, and Exercise for Calorie Burn
6 sources · 6d ago
Deep Dive
How Intermittent Fasting Compares to Continuous Calorie Restriction for Weight Loss and Metabolic Health
7 sources · 8d ago
More in Weight Loss
ExplainerGLP-1 Access
Medicare Begins Coverage of GLP-1 Drugs for Obesity: Comparing the New $50 Bridge Program vs. Cash-Pay Alternatives
Federal Health Agencies 39%Patient Advocates 39%State & Private Payers 22%
6 sources · 11d ago
GLP-1 DosingTrade-Off Analysis
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising and Dosing Comparisons
Direct Comparison Advocates 35%Maximum Efficacy Proponents 35%Clinical Pharmacists 30%
6 sources · 13d ago
ExplainerMetabolic Health
Study Finds Exercise's Primary Role in Weight Management Is Preventing Weight Regain, Not Initial Loss
Initial Weight Loss Researchers 40%Long-Term Maintenance Specialists 40%Integrative Health Analysts 20%
3 sources · 16d ago
ExplainerObesity Medicine
Triple-Agonist Retatrutide Achieves 30% Weight Loss in Trials, Matching Bariatric Surgery Efficacy
Pharmacotherapy Advocates 45%Surgical Specialists 30%Patient Advocates 25%
4 sources · 18d ago
GLP-1 TherapiesTreatment Comparison
FDA Approves Orforglipron, the First Restriction-Free Daily GLP-1 Pill for Weight Loss
Accessibility & Convenience Advocates 45%Maximum Efficacy Prioritizers 35%Clinical Safety Watchdogs 20%
6 sources · 21d ago
ExplainerMetabolic Science
Exercise Mimetics vs. GLP-1s: The Emerging Science of Preserving Muscle During Weight Loss
Clinical Obesity Specialists 40%Exercise Physiologists 35%Metabolic Researchers 25%
3 sources · 24d ago
Obesity TherapeuticsTrade-Off Analysis
Eli Lilly Grants Early Access to Next-Gen Weight-Loss Drug Retatrutide After 28.7% Trial Results
Aggressive Interventionists 40%Stepped-Care Advocates 35%Market Analysts 25%
5 sources · 29d ago
GLP-1 Side EffectsTrade-off Analysis
AI Analysis of 400,000 Patients Reveals Unreported GLP-1 Side Effects and How to Mitigate Them
Metabolic Health Advocates 40%Clinical Researchers 35%Women's Health Specialists 25%
6 sources · 32d ago · 2 updates
GLP-1 MedicationsTrade-off Analysis
FDA Approves First Oral GLP-1 Drugs for Weight Management: How Pills Compare to Injections
Patient Access Advocates 40%Clinical Efficacy Advocates 30%Primary Care Providers 30%
4 sources · 42d ago
Obesity MedicineTrade-off Analysis
New Triple-Agonist Drug Retatrutide Delivers Weight Loss Comparable to Bariatric Surgery
Pharmacological Advocates 41%Surgical Community 29%Clinical Skeptics 29%
7 sources · 53d ago
Metabolic HealthTrade-Off Analysis
Gallup Poll Finds 11% of Americans Now Take GLP-1 Drugs as Obesity Rate Declines
Public Health Optimists 45%Economic Pragmatists 30%Regulatory Cautious 25%
3 sources · 59d ago
GLP-1 ScienceTrade-Off Analysis
Wearable Data Reveals GLP-1 Weight Loss Paradox: Users Significantly Decrease Daily Physical Activity
Clinical Endocrinologists 40%Behavioral Health Experts 30%Fitness & Rehabilitation Professionals 30%
2 sources · 70d ago
ExplainerGLP-1 Science
The Science of Muscle Preservation on GLP-1 Drugs: Why Resistance Training and High Protein Are Now Essential
Exercise Physiologists 40%Clinical Pharmacologists 30%Geriatric Specialists 30%
4 sources · 73d ago
Nutrition PolicyTrade-Off Analysis
US Dietary Guidelines Shift Focus to Whole Foods and Explicitly Target Ultra-Processed Carbs
Public Health Advocates 45%Nutritional Scientists 35%Food Industry Groups 20%
5 sources · 73d ago
Deep DiveDiet Science
Time-Restricted Eating vs. Calorie Counting: What the Latest Clinical Data Reveals
Fasting Protocol Researchers 35%Evidence Synthesis Analysts 35%Energy Balance Traditionalists 30%
6 sources · 81d ago
Deep DiveDiet Science
Intermittent Fasting vs. Mediterranean Diet: Which Weight Loss Approach Fits You Best?
Time-Restricted Eating Advocates 35%Mediterranean Diet Proponents 35%Integrative Nutritionists 30%
4 sources · 81d ago
ExplainerFasting Science
Intermittent Fasting vs. The Mediterranean Diet: A Clinical Trade-Off Analysis
Metabolic Timing Proponents 35%Dietary Quality Advocates 35%Pragmatic Lifestyle Analysts 30%
5 sources · 82d ago
Deep DiveCardio Science
HIIT vs. LISS: The Science of Cardio, Calorie Burn, and Fat Loss
High-Intensity Advocates 35%Evidence-Based Consensus 35%Steady-State Proponents 30%
6 sources · 84d ago
Diet ScienceTrade-off Analysis
Intermittent Fasting vs. Caloric Restriction: Which Weight Loss Strategy Fits Your Lifestyle?
Time-Restricted Eating Advocates 40%Caloric Restriction Proponents 30%Medical Consensus 30%
3 sources · 88d ago
Medicare PolicyTrade-off Analysis
Medicare Launches $50 GLP-1 Weight Loss Program, Ending Coverage Barrier for Seniors
Patient Advocates 39%Federal Health Officials 39%Healthcare Providers 22%
2 sources · 67d ago
GLP-1 DrugsMedical Analysis
The Impact of GLP-1 Weight Loss Drugs on Muscle Mass
Medical Community 40%Fitness Professionals 35%Pharma Innovators 25%
3 sources · 99d ago
Obesity TherapeuticsMechanism Compare
Scientists Uncover Exercise-Induced Molecule That Suppresses Appetite, Hinting at New Weight Loss Drug
Metabolic Researchers 40%Sarcopenia Prevention Advocates 35%Clinical Practitioners 25%
4 sources · 63d ago